Guardant Health, Inc.
GH
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancā¦ read more
Healthcare
Diagnostics & Research
7 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$168.30
Price+0.25%
$0.42
1Y
Price
Market Cap
$22.585b
Large
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-32.5%
EBITDA Margin-35.9%
Net Profit Margin-20.8%
Free Cash Flow Margin-32.5%
EBITDA Margin-35.9%
Net Profit Margin-20.8%
Free Cash Flow MarginRevenue
$1.183b
+20.5%
1y CAGR+28.1%
3y CAGR+27.5%
5y CAGREarnings
-$453.436m
-8.9%
1y CAGR+1.6%
3y CAGR+7.9%
5y CAGREPS
-$3.49
-5.1%
1y CAGR+6.2%
3y CAGR+12.9%
5y CAGRBook Value
-$222.867m
$1.912b
Assets$2.135b
Liabilities$1.669b
DebtDebt to Assets
87.3%
-4.1x
Debt to EBITDAFree Cash Flow
-$240.724m
-3.3%
1y CAGR+10.8%
3y CAGR+10.8%
5y CAGRNo items found.
Press Releases
Statements and updates from the company